Diabetes Treatment

Report: Endocrinologists, PCPs have different rationales driving choice of meds

Published in Obesity and Diabetes Week, December 27th, 2004

Decision Resources, Inc., reports that endocrinologists and primary care physicians (PCPs) have different rationales driving their choice of prescription anti-diabetic drugs.

Surveyed primary care physicians are more sensitive to cost and formulary status of anti-diabetic agents than are endocrinologists.

"More primary care physicians than endocrinologists cite these two reasons as significant factors that influence their choice of therapies," said Donny Wong, PhD, analyst at Decision Resources. "Endocrinologists, on the other hand, are uniformly more concerned about safety and side effects than are primary care physicians."

The...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week

Source: Obesity and Diabetes Week (2004-12-27)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry